Literature DB >> 17290400

Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells.

Takashi Ishigami1, Katsuhiro Uzawa, Morihiro Higo, Hitomi Nomura, Kengo Saito, Yoshikuni Kato, Dai Nakashima, Masashi Shiiba, Hiroki Bukawa, Hidetaka Yokoe, Tetsuya Kawata, Hisao Ito, Hideki Tanzawa.   

Abstract

To identify genes associated with radioresistant oral squamous cell carcinoma (OSCC), we compared gene expression signatures between OSCC cell lines exhibiting radioresistance and cells with radiosensitivity after X-ray irradiation in a dose-dependent manner using Affymetrix GeneChip analysis with Human Genome-U133 plus 2.0 GeneChip. The microarray data identified 167 genes that were significantly overexpressed in radioresistant cells after X-ray irradiation. Among the genes identified, 40 were mapped to 3 highly significant genetic networks identified by the Ingenuity Pathway Analysis tool. Gene ontology analysis showed that cancer-related function had the highest significance. The 40 genes included 25 cancer-related genes that formed 1 network and were categorized by function into growth and proliferation, apoptosis, and adhesion. Furthermore, real-time quantitative reverse transcriptase-polymerase chain reaction showed that the mRNA expression levels of the 25 genes were higher in radioresistant cells than in radiosensitive cells in a dose-dependent manner and in a time-dependent manner. Our results suggest that the identified genes help to elucidate the molecular mechanisms of the radioresistance of OSCC and could be radiotherapeutic molecular markers for choosing the appropriate radiotherapy for this disease. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17290400     DOI: 10.1002/ijc.22561

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  Overexpression of KLF13 and FGFR3 in oral cancer cells.

Authors:  B J Henson; S M Gollin
Journal:  Cytogenet Genome Res       Date:  2010-06-02       Impact factor: 1.636

Review 2.  Association between radiation-induced cell death and clinically relevant radioresistance.

Authors:  Yoshikazu Kuwahara; Kazuo Tomita; Yusuke Urushihara; Tomoaki Sato; Akihiro Kurimasa; Manabu Fukumoto
Journal:  Histochem Cell Biol       Date:  2018-09-20       Impact factor: 4.304

Review 3.  Roles of FGFR in oral carcinogenesis.

Authors:  Xiaoyan Xie; Zhiyong Wang; Fangman Chen; Yao Yuan; Jiayi Wang; Rui Liu; Qianming Chen
Journal:  Cell Prolif       Date:  2016-06       Impact factor: 6.831

4.  Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas.

Authors:  Michael M Fisher; Gopika SenthilKumar; Rong Hu; Steve Goldstein; Irene M Ong; Margot C Miller; Sean R Brennan; Saakshi Kaushik; Lindsey Abel; Kwangok P Nickel; Gopal Iyer; Paul M Harari; Randall J Kimple; Andrew M Baschnagel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-13       Impact factor: 7.038

Review 5.  Molecular techniques and genetic alterations in head and neck cancer.

Authors:  Patrick K Ha; Steven S Chang; Chad A Glazer; Joseph A Califano; David Sidransky
Journal:  Oral Oncol       Date:  2008-07-31       Impact factor: 5.337

6.  Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.

Authors:  Brian J Henson; Samsiddhi Bhattacharjee; Dawn M O'Dee; Eleanor Feingold; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2009-07       Impact factor: 5.006

7.  Gene network and canonical pathway analysis in prostate cancer: a microarray study.

Authors:  Hakan Savli; Attila Szendröi; Imre Romics; Balint Nagy
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

8.  Alteration of apoptotic signaling molecules as a function of time after radiation in human neuroblastoma cells.

Authors:  Natarajan Aravindan; Rakhesh Madhusoodhanan; Mohan Natarajan; Terence S Herman
Journal:  Mol Cell Biochem       Date:  2007-12-09       Impact factor: 3.396

9.  Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting (111)In-Trastuzumab for Potential Combination Therapies.

Authors:  Huizi Keiko Li; Yukie Morokoshi; Kazuhiro Daino; Takako Furukawa; Tadashi Kamada; Tsuneo Saga; Sumitaka Hasegawa
Journal:  Cancer Biother Radiopharm       Date:  2015-10       Impact factor: 3.099

10.  FGFR Inhibition Enhances Sensitivity to Radiation in Non-Small Cell Lung Cancer.

Authors:  Gopika SenthilKumar; Michael M Fisher; Justin H Skiba; Margot C Miller; Sean R Brennan; Saakshi Kaushik; Samantha T Bradley; Colin A Longhurst; Darya Buehler; Kwangok P Nickel; Gopal Iyer; Randall J Kimple; Andrew M Baschnagel
Journal:  Mol Cancer Ther       Date:  2020-05-05       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.